SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol
심혈관 위험 인자가 있는 환자의 SARS-CoV-2 체액성 면역 반응: 커뮤니티 코호트 연구 프로토콜
Article
[키워드] Adult patients
anti-SARS-CoV-2 vaccine
anti-SARS-CoV-2 vaccines
antibody
approved
baseline
blood sample
cardiovascular
cardiovascular risk
cardiovascular risk factors
clinics
Cohort
collected
Community
conducted
Contact
contact with
COVID-19
death
defined
detectable
determine
disseminate
eligible
Epidemiology
Ethics
ethics committee
exposure
exposure to
face-to-face contact
follow-up time
Health care
humoral immune response
IgG antibody
immunology
Inclusion
International
Local
Memorandum
mixed-effects model
morbidity
National
neutralising
Neutralising Antibodies
neutralising antibody
outcome
pandemic
participant
Patient
peer-reviewed
Prevent
primary care
Primary outcome
Primary outcomes
prospective cohort study
protocol
questionnaire
recruitment
Registered
Research
Sample size
SARS-CoV-2
SARS-CoV-2 antigen
SARS-CoV-2 antigens
secondary
Secondary outcomes
Seroconversion
service
South
strength
Study protocol
vaccination
website
[DOI] 10.1136/bmjopen-2022-061345 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/bmjopen-2022-061345 PMC 바로가기 [Article Type] Article